Botanical immunodrugs: scope and opportunities
- PMID: 15809195
- PMCID: PMC7128543
- DOI: 10.1016/S1359-6446(04)03357-4
Botanical immunodrugs: scope and opportunities
Abstract
Modulation of the immune system can be addressed through a variety of specific and non-specific approaches. Many agents of synthetic and natural origin have stimulatory, suppressive or regulatory activity. There is growing evidence that drugs or biological agents capable of modulating single pathways or targets are of limited value as immune-related therapies. Systems biology approaches are now gaining more interest compared with monovalent approaches, which can be of limited benefits with complications. This has stimulated interest in the use of 'cocktails' of immunodrugs to restore immunostasis. Botanicals are chemically complex and diverse and could therefore provide appropriate combinations of synergistic moieties useful in drug discovery. Here, the importance of traditional medicine in natural product drug discovery related to immunodrugs is reviewed.
Figures


Similar articles
-
Herbs and other botanicals in cancer patient care.Curr Treat Options Oncol. 2008 Jun;9(2-3):109-16. doi: 10.1007/s11864-008-0061-5. Epub 2008 Jul 9. Curr Treat Options Oncol. 2008. PMID: 18612829 Review.
-
Botanical drugs: challenges and opportunities: contribution to Linnaeus Memorial Symposium 2007.Life Sci. 2008 Feb 27;82(9-10):445-9. doi: 10.1016/j.lfs.2007.11.007. Epub 2007 Nov 29. Life Sci. 2008. PMID: 18177674 Review.
-
Botanical therapies in chronic fatigue.Phytother Res. 2006 Feb;20(2):91-5. doi: 10.1002/ptr.1794. Phytother Res. 2006. PMID: 16444659 Review.
-
Strategies for designing synthetic immune agonists.Immunology. 2016 Aug;148(4):315-25. doi: 10.1111/imm.12622. Epub 2016 Jul 11. Immunology. 2016. PMID: 27213842 Free PMC article. Review.
-
Evidence-based botanical research: applications and challenges.Hematol Oncol Clin North Am. 2008 Aug;22(4):661-70, viii. doi: 10.1016/j.hoc.2008.04.007. Hematol Oncol Clin North Am. 2008. PMID: 18638694 Review.
Cited by
-
Immunomodulatory effects of an enzymatic extract from Ecklonia cava on murine splenocytes.Mar Biotechnol (NY). 2008 May-Jun;10(3):278-89. doi: 10.1007/s10126-007-9062-9. Epub 2008 Jan 3. Mar Biotechnol (NY). 2008. PMID: 18172723
-
The in vitro anti-viral potential of Setarud (IMOD™), a commercial herbal medicine with protective activity against acquired immune deficiency syndrome in clinical trials.Indian J Pharmacol. 2012 Jul-Aug;44(4):448-53. doi: 10.4103/0253-7613.99301. Indian J Pharmacol. 2012. PMID: 23087503 Free PMC article.
-
Saussurea lappa Ethanolic Extract Attenuates Triamcinolone Acetonide-Induced Pulmonary and Splenic Tissue Damage in Rats via Modulation of Oxidative Stress, Inflammation, and Apoptosis.Antioxidants (Basel). 2020 May 8;9(5):396. doi: 10.3390/antiox9050396. Antioxidants (Basel). 2020. PMID: 32397156 Free PMC article.
-
Theories and management of aging: modern and ayurveda perspectives.Evid Based Complement Alternat Med. 2011;2011:528527. doi: 10.1093/ecam/nep005. Epub 2011 Jun 8. Evid Based Complement Alternat Med. 2011. PMID: 19233879 Free PMC article.
-
Exploratory studies on the therapeutic effects of Kumarabharana Rasa in the management of chronic tonsillitis among children at a tertiary care hospital of Karnataka.J Tradit Complement Med. 2015 Jan 16;6(1):29-33. doi: 10.1016/j.jtcme.2014.11.031. eCollection 2016 Jan. J Tradit Complement Med. 2015. PMID: 26870676 Free PMC article.
References
-
- Oberholzer A. Cytokine signaling-regulation of the immune response in normal and critically ill states. Crit. Care Med. 2000;28:N3–N12. - PubMed
-
- Nelson R.P., Jr, Ballow M. Immunomodulation and immunotherapy: drugs, cytokines, cytokine receptors, and antibodies. J. Allergy Clin. Immunol. 2003;111:S720–S743. - PubMed
-
- Geissler M., Weth R. Immunotherapy: new insights. Schweiz. Rundsch. Med. Prax. 2002;91:2236–2246. - PubMed
-
- Whelan M. Cancer immunotherapy: an embarrassment of riches. Drug Discov. Today. 2003;8:253–258. - PubMed
-
- Chada S. Cytokine- and chemokine-based gene therapy for cancer. Curr. Opin. Mol. Ther. 2003;5:463–474. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources